Managing adherence, exposure, and toxicity in oral anticancer therapies

被引：0
|
作者：
Kazuo Kobayashi [1 ]
机构：
[1] The Cancer Institute Hospital of JFCR,Department of Pharmacy
来源：
Journal of Pharmaceutical Health Care and Sciences | / 11卷 / 1期
关键词：
Oral anticancer agents; Adherence; Occupational exposure; Hand-foot skin reaction; Hypothyroidism; Pharmacist intervention; Medication safety; Oncology pharmacy; Patient education; Adverse effect management;
D O I：
10.1186/s40780-025-00437-2
中图分类号：
学科分类号：
摘要：
The management of adherence, exposure risk, and adverse effects in oral anticancer agents (OAAs) is essential for optimizing patient outcomes in oncology pharmacy. This review highlights key efforts to enhance adherence, reduce occupational exposure, and improve adverse effect management in OAA therapy.
引用
收藏
相关论文
共 50 条
  • [1] Oral toxicity of targeted anticancer therapies
    Sibaud, V.
    Boralevi, F.
    Vigarios, E.
    Fricain, J. -C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 (05): : 354 - 363
  • [2] Impact of cognitive functions on oral anticancer therapies adherence
    Dos Santos, M.
    Lange, M.
    Clarisse, B.
    Barillet, M.
    Joly, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] An interprofessional medication adherence program to optimize adherence to oral anticancer therapies: a randomized-controlled trial
    Bandiera, Carole
    Cardoso, Evelina
    Locatelli, Isabella
    Digklia, Antonia
    Zaman, Khalil
    Diciolla, Antonella
    Cristina, Vale Prime Rie
    Stravodimou, Athina
    Veronica, Aedo-Lopez
    Dolcan, Ana
    Sarivalasis, Apostolos
    Bouchaab, Hasna
    Liapi, Aikaterini
    Orcurto, Angela
    Dotta-Celio, Jennifer
    Peters, Solange
    Decosterd, Laurent
    Widmer, Nicolas
    Wagner, Dorothea
    Csajka, Chantal
    Schneider, Marie P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01)
  • [4] Adherence with Oral Anticancer Agents
    Timmers, Lonneke
    Kropff, Femke
    Boons, Christel C. L. M.
    van de Ven, Peter
    Swart, Eleonora L.
    Boven, Epie
    Hugtenburg, Jacqueline
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 460 - 461
  • [5] Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence
    Mélanie Dos Santos
    M. Lange
    R. Gervais
    B. Clarisse
    A. Capel
    M. Barillet
    J. M. Grellard
    N. Heutte
    I. Licaj
    F. Joly
    Supportive Care in Cancer, 2019, 27 : 3573 - 3581
  • [6] Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence
    Dos Santos, Melanie
    Lange, M.
    Gervais, R.
    Clarisse, B.
    Capel, A.
    Barillet, M.
    Grellard, J. M.
    Heutte, N.
    Licaj, I.
    Joly, F.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (09) : 3573 - 3581
  • [7] Adherence to novel oral anticancer therapies in the phase I setting: The Royal Marsden experience.
    Chenard-Poirier, Maxime
    Ang, Joo Ern
    Harris, Samuel John
    Garces, Alvaro Henrique Ingles
    Seeramreddi, Satyanarayana
    Sundar, Raghav
    Collins, Dearbhaile Catherine
    Ameratunga, Malaka
    Lopez, Juanita Suzanne
    De Bono, Johann S.
    Banerji, Udai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Oral Mucositis Induced By Anticancer Therapies
    Al-Ansari S.
    Zecha J.A.E.M.
    Barasch A.
    de Lange J.
    Rozema F.R.
    Raber-Durlacher J.E.
    Current Oral Health Reports, 2015, 2 (4) : 202 - 211
  • [9] Patient adherence with oral anticancer treatment
    Costantini, A.
    Santoleri, F.
    Sorice, P.
    Scurti, V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 965 - 966
  • [10] Patient adherence to oral anticancer drugs
    Eberl, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S28 - S28
12345